Medicare disability recipient dies of brain tumor after having coverage interrupted

Milwaukee Journal Sentinel: "Paula Oertel, whose brain tumor disappeared for nine years while she was on an expensive drug and returned after she temporarily lost her insurance coverage, has died as a result of the tumor spreading through her brain. The interruption of her Medicare coverage of the drug directly contributed to her death, contends her doctor, Mark Malkin, chief of neuro-oncology at Froedtert Hospital. … She was diagnosed with glioblastoma multiforme 12 years ago when she was 29. The tumor is highly malignant and the most common primary malignant brain tumor in adults, affecting about 9,000 Americans a year. … As a last resort, doctors tried beta interferon, which has shown some promise but is not approved to treat brain cancer. … Within months the tumor disappeared, and for nine years there was no sign of it on repeated brain scans. Medicare paid for the drug for the next nine years. Due to a mix-up, Oertel temporarily lost her Medicare health coverage in November 2007" (Fauber, 8/12).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study unveils why glioblastoma becomes resistant to treatment